Metagenomi Therapeutics, Inc. Temporary Equity, Liquidation Preference
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2025-03-17
- 2023-12-31: Temporary Equity, Liquidation Preference $352.04M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2023-12-31 | $352.04M 10-K · filed 2025-03-17 |